WBR0920
Author | PageAuthor::Vendhan Ramanujam |
---|---|
Exam Type | ExamType::USMLE Step 3 |
Main Category | MainCategory::Community Medical Health Center, MainCategory::Primary Care Office, MainCategory::Inpatient Facilities |
Sub Category | SubCategory::Endocrine |
Prompt | [[Prompt::A 18 year old boy is brought to the physicians office by his mother, with complains of sweats and headaches during the nights. Initially he was started on NPH insulin, 30 U each morning and 15 U every night. But following a persistent morning glycosuria that did not improve, the evening dose was increased to 20 U during his last visit. His recent lab tests reveal worsening of his morning glycosuria with moderate ketones in his urine. Several consecutive nights glucose monitoring was done and it revealed hypoglycemia. Somogyi phenomenon is diagnosed. What will be the next best step in management of this patient]] |
Answer A | AnswerA::Increasing the evening dose of insulin |
Answer A Explanation | AnswerAExp::'''Incorrect'''-Increasing the evening dose of insulin will only worsen this condition. |
Answer B | AnswerB::Switching from NPH to lispro |
Answer B Explanation | [[AnswerBExp::Incorrect-Switching from NPH to lispro will not be required now.]] |
Answer C | AnswerC::Increasing the morning dose of insulin |
Answer C Explanation | AnswerCExp::'''Incorrect'''-Increasing the morning dose of insulin will be necessary only if there was an increase in early morning blood glucose without a hypoglycemic episode at night, which is Dawn phenomenon. |
Answer D | AnswerD::Switching from NPH to regular insulin |
Answer D Explanation | [[AnswerDExp::Incorrect-Switching from intermediately acting NPH insulin to short acting regular insulin might not be effective since both have a duration of action above 12 hours following their evening or night administration leading to nocturnal hypoglycemia.]] |
Answer E | AnswerE::Decreasing the evening dose of insulin |
Answer E Explanation | AnswerEExp::'''Correct'''-After documentation of hypoglycemia during night and confirmation of Somogyi phenomenon, reducing the evening or night insulin dose (short acting or intermediate acting) is the first appropriate step in management. |
Right Answer | RightAnswer::E |
Explanation | [[Explanation::Early morning rebound hyperglycemia in insulin dependent diabetes mellitus patients follows episodic hypoglycemia at night. This response is called as Somogyi phenomenon. It develops in response to excessive insulin administration. An adenergic response to hypoglycemia results in increased glycogenolysis, gluconeogenesis and diminished glucose uptake by peripheral tissues. The first step in managing this condition will be documentation of hypoglycemia during night. Following the confirmation, the evening or night insulin dose (short acting or intermediate acting) can be reduced. Further more, substitution of evening or night short acting or intermediate acting insulin with rapidly acting insulin like lispro may be of some help.
Educational Objective:
Episodic hypoglycemia at night followed by rebound hyperglycemia is called as Somogyi phenomenon, which occurs in insulin dependent diabetes mellitus patients who are on insulin. The first step in managing this condition will be documentation of hypoglycemia during night. Following the confirmation, the evening or night insulin dose can be reduced. Furthermore, substitution of evening or night short acting or intermediate acting insulin with rapidly acting insulin like lispro may be of some help. |
Approved | Approved::Yes |
Keyword | WBRKeyword::Somogyi phenomenon |
Linked Question | Linked:: |
Order in Linked Questions | LinkedOrder:: |